Abeona Will Include Early-stage MPS IIIA Patients in ABO-102 Gene Therapy Trial
News
Abeona Therapeutics is planning to expand its ongoing ABO-102 gene therapy Phase 1/2 trial to include patients with Sanfilippo syndrome type A (MPS IIIA) at earlier stages of the ... Read more